DK0941085T3 - Anordning til elektrisk hjulpet uddeling af stof, såsom lidocain og ephinephrin - Google Patents

Anordning til elektrisk hjulpet uddeling af stof, såsom lidocain og ephinephrin

Info

Publication number
DK0941085T3
DK0941085T3 DK97946508T DK97946508T DK0941085T3 DK 0941085 T3 DK0941085 T3 DK 0941085T3 DK 97946508 T DK97946508 T DK 97946508T DK 97946508 T DK97946508 T DK 97946508T DK 0941085 T3 DK0941085 T3 DK 0941085T3
Authority
DK
Denmark
Prior art keywords
lidocaine
electrically assisted
ephinephrine
drug
assisted delivery
Prior art date
Application number
DK97946508T
Other languages
English (en)
Inventor
Andreas Linkwitz
Ivan W Chin
Richard J Gyory
Ronald V Thompson
Paul J Urbanski
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21856113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0941085(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0941085T3 publication Critical patent/DK0941085T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK97946508T 1996-11-14 1997-11-03 Anordning til elektrisk hjulpet uddeling af stof, såsom lidocain og ephinephrin DK0941085T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3080096P 1996-11-14 1996-11-14
PCT/US1997/020056 WO1998020869A2 (en) 1996-11-14 1997-11-03 Formulation for electrically assisted delivery of lidocaine and epinephrine

Publications (1)

Publication Number Publication Date
DK0941085T3 true DK0941085T3 (da) 2003-08-11

Family

ID=21856113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97946508T DK0941085T3 (da) 1996-11-14 1997-11-03 Anordning til elektrisk hjulpet uddeling af stof, såsom lidocain og ephinephrin

Country Status (12)

Country Link
EP (1) EP0941085B1 (da)
JP (1) JP2001505197A (da)
KR (1) KR100534512B1 (da)
CN (1) CN1155372C (da)
AT (1) ATE238046T1 (da)
AU (1) AU721114B2 (da)
CA (1) CA2271944C (da)
DE (1) DE69721293T2 (da)
DK (1) DK0941085T3 (da)
ES (1) ES2194222T3 (da)
PT (1) PT941085E (da)
WO (1) WO1998020869A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ511464A (en) 1998-11-02 2003-07-25 Alza Corp Electrotransport device including a compatible antimicrobial agent
EP1133985A4 (en) * 1998-11-26 2004-03-31 Hisamitsu Pharmaceutical Co SELF-ADHESIVE ADHESIVE GEL COMPOSITION FOR IONOPHORESIS AND APPARATUS THEREOF
US6629968B1 (en) 2000-06-30 2003-10-07 Vyteris, Inc. Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
JPWO2005020967A1 (ja) * 2003-08-29 2007-11-01 久光製薬株式会社 電気的薬物移送製剤
US20050228335A1 (en) 2004-04-07 2005-10-13 Reddy Vilambi N Physical, structural, mechanical, electrical and electromechanical features for use in association with electrically assisted delivery devices and systems
US20050228336A1 (en) 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
WO2007041158A1 (en) 2005-09-30 2007-04-12 Vyteris, Inc. Iontophoresis drug delivery device providing acceptable depth and duration of dermal anesthesia
US20070078372A1 (en) * 2005-09-30 2007-04-05 Vyteris, Inc. Iontophoresis Drug Delivery Formulation Providing Acceptable Sensation and Dermal Anesthesia
JP5116482B2 (ja) 2005-11-14 2013-01-09 帝國製薬株式会社 イオントフォレーシス用製剤
CN105902482A (zh) 2008-06-25 2016-08-31 Fe3医学有限公司 用于经皮递送治疗有效量的铁的贴片和方法
GB0815051D0 (en) * 2008-08-18 2008-09-24 Univ Dundee Apparatus and method for mineralising biological materials
JP2012524604A (ja) * 2009-04-25 2012-10-18 インキューブ ラブズ， エルエルシー キレート剤の経皮的イオン導入送達のための方法
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
WO2010139752A2 (en) 2009-06-04 2010-12-09 Alk Ag Stabilised composition comprising at least one adrenergic compound
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
US20170189352A1 (en) 2015-03-13 2017-07-06 Par Pharmaceutical, Inc. Epinephrine formulations
US9119876B1 (en) * 2015-03-13 2015-09-01 Par Pharmaceutical, Inc. Epinephrine formulations
CA3034640A1 (en) * 2016-08-25 2018-03-01 Imprimis Pharmaceuticals, Inc. Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
WO2019072723A1 (en) 2017-10-10 2019-04-18 Merck Patent Gmbh STABILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS OF L-EPINEPHRINE
WO2019183416A1 (en) 2018-03-23 2019-09-26 Nevakar Inc. Epinephrine compositions and containers
US11331478B2 (en) * 2018-06-14 2022-05-17 United States Government As Represented By The Department Of Veterans Affairs Wireless iontophoresis patch and controller

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA981182A (en) * 1972-01-07 1976-01-06 Walter A. Borisenok Stabilization of 1-epinephrine in local anesthetic solutions with a combination of three antioxidants
AU615188B2 (en) * 1987-05-28 1991-09-26 Drug Delivery Systems Inc. Pulsating transdermal drug delivery system
JPS6411565A (en) * 1987-07-03 1989-01-17 Nitto Denko Corp Drug admistrating method by iontophoresis
US5261903A (en) * 1988-04-11 1993-11-16 M.D. Inc. Composite anesthetic article and method of use
US5047007A (en) * 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
ATE143279T1 (de) * 1991-12-03 1996-10-15 Alza Corp Iontophoretische verbreichungsvorrichtung und versorgungsnetz dafür
US5540669A (en) * 1993-09-30 1996-07-30 Becton, Dickinson And Company Iontophoretic drug delivery system and method for using same
US5563153A (en) * 1995-02-22 1996-10-08 University Of Kansas Medical Center Sterile topical anesthetic gel

Also Published As

Publication number Publication date
CA2271944C (en) 2008-04-29
WO1998020869A3 (en) 1998-07-23
DE69721293D1 (de) 2003-05-28
KR100534512B1 (ko) 2005-12-08
CN1155372C (zh) 2004-06-30
DE69721293T2 (de) 2004-01-29
JP2001505197A (ja) 2001-04-17
AU5166398A (en) 1998-06-03
ATE238046T1 (de) 2003-05-15
EP0941085B1 (en) 2003-04-23
WO1998020869A2 (en) 1998-05-22
ES2194222T3 (es) 2003-11-16
KR20000053270A (ko) 2000-08-25
CA2271944A1 (en) 1998-05-22
CN1237907A (zh) 1999-12-08
AU721114B2 (en) 2000-06-22
PT941085E (pt) 2003-08-29
EP0941085A2 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
DK0941085T3 (da) Anordning til elektrisk hjulpet uddeling af stof, såsom lidocain og ephinephrin
ATE413386T1 (de) Ppar-gamma modulatoren
NO20001287L (no) Farmasøytisk blanding for behandling av dysmenoré og for tidlig fødsel
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
DK2018874T3 (da) Farmaceutiske sammensætninger til forebyggelse og behandling af lidelser i centralnervesystemet indeholdende en nikotinisk agonist og en acetylcholinesteraseinhibitor
NO20031266D0 (no) Kondenserte heterocykliske suksinimid-forbindelser og analoger derav, modulatorer for nukle¶r hormonreseptorfunksjon
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
NO985574L (no) FremgangsmÕter og preparater anvendelige for inhibering av angiogenese
IS6560A (is) Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni
IS1846B (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
NO20003550D0 (no) Farmasøytiske sammensetninger og anvendelse herav
IT1285387B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
ID26033A (id) Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
DK1117403T3 (da) MGLUR5-antagonister til behandling af smerte og angst
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
PT1191927E (pt) Sistema de microrreservatorios a base de polissiloxanos e solventes ambifilicos
DK0952959T3 (da) Polyhalophosphazenopløsninger, som er stabile overfor geldannelse
DK1267833T3 (da) Farmaceutiske præparater og fremgangsmåde til fremstilling deraf
DE69928375D1 (de) Analgetikum aus schlangengift
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DK1161239T3 (da) 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose